Spotlight on GLP-1 Therapies
GLP-1 receptor agonists are driving new conversations in clinical care, with emerging evidence informing their use across diabetes, obesity, cardiovascular disease, and metabolic health. Stay ahead of the conversation with Spotlight on GLP-1 Therapies,your go-to source for expert perspectives and timely updates on the developments shaping this dynamic clinical landscape.
Real-World Effectiveness of Liraglutide for Obesity: Multicenter Data From Turkey
Clinician's RoundtableReal-World Effectiveness of Liraglutide for Obesity: Multicenter Data From Turkey
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
GI InsightsNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
- advertisement
- 05/25/2026
- 05/21/2026
- 05/18/2026
- 05/14/2026
- 05/15/2026
- 05/13/2026



















